Oshima Y, Oida H, Emi K
Department of Ophthalmology, Osaka Rosai Hospital, Japan.
J Cataract Refract Surg. 1998 Sep;24(9):1223-9. doi: 10.1016/s0886-3350(98)80016-3.
To evaluate the safety and efficacy of transscleral ciliary sulcus fixation of acrylic intraocular lenses (IOLs) through small incisions in the management of secondary IOL implantation.
Department of Ophthalmology, Osaka Rosai Hospital, Osaka, Japan.
This retrospective study consisted of 28 patients (30 eyes) who had transscleral fixation of acrylic IOLs through 3.5 mm incisions. All patients were followed for a minimum of 6 months in several different clinical settings. Data on visual acuity, keratometry, and central corneal endothelial cell count were evaluated preoperatively and postoperatively. The refractive error achieved and incidence of postoperative complications were determined.
Uncorrected visual acuity (UCVA) improved in all eyes. Of the 18 eyes without pre-existing pathology, 11 (61.1%) had a UCVA of 20/40 or better from 1 week postoperatively. Best corrected visual acuity was unchanged in 24 eyes (80.0%) and improved by 2 Snellen lines or more in 5 eyes (16.7%) at the final examination. Self-sealing wound adaptation was achieved in 25 eyes (83.3%). The mean scalar shift in keratometric cylinder was 1.25 diopters (D) at 1 day postoperatively, 1.17 D at 1 week, and 1.06 D at 3 months. The rate of central corneal endothelial loss 6 months postoperatively averaged 7.84%. No intraoperative complications that were directly associated with acrylic IOL implantation occurred. Postoperative complications that included transient ocular hypertension, slight vitreous hemorrhage, and IOL malposition were found in a small population but resolved spontaneously without further surgical intervention.
The good visual outcomes and low incidence of complications achieved in the present study indicate that acrylic IOLs positioned through small incisions might be considered for ciliary sulcus fixation. However, evaluation of this technique in a large population over the long term is required.
评估经巩膜睫状沟固定丙烯酸人工晶状体(IOL)通过小切口在二期人工晶状体植入术中的安全性和有效性。
日本大阪罗萨伊医院眼科。
这项回顾性研究包括28例患者(30只眼),他们通过3.5毫米切口进行了丙烯酸人工晶状体的经巩膜固定。所有患者在几种不同临床环境中至少随访6个月。术前和术后评估视力、角膜曲率和中央角膜内皮细胞计数数据。确定达到的屈光不正和术后并发症发生率。
所有眼的未矫正视力(UCVA)均有改善。在18只无既往病变的眼中,11只(61.1%)术后1周时UCVA达到20/40或更好。最终检查时,24只眼(80.0%)的最佳矫正视力未改变,5只眼(16.7%)提高了2行或更多Snellen视力表行数。25只眼(83.3%)实现了自闭式伤口愈合。术后1天角膜散光平均轴向移位为1.25屈光度(D),术后1周为1.17 D,术后3个月为1.06 D。术后6个月中央角膜内皮细胞丢失率平均为7.84%。未发生与丙烯酸人工晶状体植入直接相关的术中并发症。术后并发症包括短暂性眼压升高、轻微玻璃体出血和人工晶状体位置异常,在少数患者中出现,但无需进一步手术干预即可自行缓解。
本研究取得的良好视力结果和低并发症发生率表明,通过小切口定位的丙烯酸人工晶状体可考虑用于睫状沟固定。然而,需要对大量人群进行长期的该技术评估。